Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Hodson

Showing results (11-20 of 59) with videos related to

Pageof 6
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the ChallengeNatasha H Cutmore, Joanna A Krupka, Daniel J Hodson
British Journal of Haematology|September 1, 2021
Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?Ryan D Morin, Sarah E Arthur, Daniel J Hodson
Blood Advances|January 24, 2025
Audit of B-cell cancer genesKrysta M Coyle, Kostiantyn Dreval, Daniel J Hodson, et al.
Histopathology|November 15, 2024
Evolving molecular classification of aggressive B-cell lymphomaStefan K Alig, Björn Chapuy, Daisuke Ennishi, et al.
Nature Protocols|April 10, 2021
Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cellsRebecca Caeser, Jie Gao, Miriam Di Re, et al.
Open Biology|September 30, 2016
Challenging perspectives on the cellular origins of lymphomaTim I M Malcolm, Daniel J Hodson, Elizabeth A Macintyre, et al.
JCO Precision Oncology|February 5, 2021
Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell LymphomaRebecca Caeser, Ieuan Walker, Jie Gao, et al.
Blood|May 14, 2021
SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independenceJie Gao, Eirini Sidiropoulou, Ieuan Walker, et al.
Blood Cancer Discovery|May 12, 2026
Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell LymphomaMargaret A Shipp, Louis M Staudt, Daniel J Hodson, et al.
British Journal of Haematology|October 3, 2020
Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)Hendrik F P Runge, Stuart Lacy, Sharon Barrans, et al.
Pageof 6

Showing results (11-20 of 59) with videos related to

Sort By:
Pageof 6
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Genetic Profiling in Diffuse Large B-Cell Lymphoma: The Promise and the ChallengeNatasha H Cutmore, Joanna A Krupka, Daniel J Hodson
British Journal of Haematology|September 1, 2021
Molecular profiling in diffuse large B-cell lymphoma: why so many types of subtypes?Ryan D Morin, Sarah E Arthur, Daniel J Hodson
Blood Advances|January 24, 2025
Audit of B-cell cancer genesKrysta M Coyle, Kostiantyn Dreval, Daniel J Hodson, et al.
Histopathology|November 15, 2024
Evolving molecular classification of aggressive B-cell lymphomaStefan K Alig, Björn Chapuy, Daisuke Ennishi, et al.
Nature Protocols|April 10, 2021
Genetic manipulation and immortalized culture of ex vivo primary human germinal center B cellsRebecca Caeser, Jie Gao, Miriam Di Re, et al.
Open Biology|September 30, 2016
Challenging perspectives on the cellular origins of lymphomaTim I M Malcolm, Daniel J Hodson, Elizabeth A Macintyre, et al.
JCO Precision Oncology|February 5, 2021
Acquired CARD11 mutation promotes BCR independence in Diffuse Large B Cell LymphomaRebecca Caeser, Ieuan Walker, Jie Gao, et al.
Blood|May 14, 2021
SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independenceJie Gao, Eirini Sidiropoulou, Ieuan Walker, et al.
Blood Cancer Discovery|May 12, 2026
Laying the Foundation for Clinically Actionable Genomic Subtyping in Diffuse Large B-cell LymphomaMargaret A Shipp, Louis M Staudt, Daniel J Hodson, et al.
British Journal of Haematology|October 3, 2020
Application of the LymphGen classification tool to 928 clinically and genetically-characterised cases of diffuse large B cell lymphoma (DLBCL)Hendrik F P Runge, Stuart Lacy, Sharon Barrans, et al.
Pageof 6